0001607854-16-000003.txt : 20161006 0001607854-16-000003.hdr.sgml : 20161006 20161006165316 ACCESSION NUMBER: 0001607854-16-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161006 DATE AS OF CHANGE: 20161006 EFFECTIVENESS DATE: 20161006 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lysosomal Therapeutics, Inc. CENTRAL INDEX KEY: 0001607854 IRS NUMBER: 454015802 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-272003 FILM NUMBER: 161925308 BUSINESS ADDRESS: STREET 1: 19 BLACKSTONE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-714-9620 MAIL ADDRESS: STREET 1: 19 BLACKSTONE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0707 D LIVE 0001607854 Lysosomal Therapeutics, Inc. 19 BLACKSTONE STREET CAMBRIDGE MA MASSACHUSETTS 02139 617-714-9620 DELAWARE None None Corporation true 2011 Cornelis Been c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Robert Carpenter c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Bruce Booth c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Bernard Davitian c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Steven Hall c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Carole Nuechterlein c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Clay Thorp c/o Lysosomal Therapeutics, Inc. 19 Blackstone Street Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2016-10-03 false true true false 0 6000000 6000000 0 false 9 0 0 250000 true false Lysosomal Therapeutics, Inc. /s/ Cornelis Been Cornelis Been President & CEO 2016-10-05